• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US. CORP SABER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US. CORP SABER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Catalog Number 48005020X
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/18/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Event or Problem Description
As reported, leakage was detected when inflating the balloon of a 5mm x 20cm saber percutaneous transluminal angioplasty (pta) balloon catheter.An unknown device was used as a replacement.There were no reported injuries to the patient or signs of infectious disease.This was during a balloon dilatation of the left superficial femoral artery (sfa).The device will be returned for evaluation.
 
Additional Manufacturer Narrative
After further review of additional information received the following sections have been updated accordingly: b4, b5, d9, g3, g6, h1, h2, h3, h6, and h11.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event or Problem Description
As reported, leakage was detected when inflating the balloon of a 5mm x 20cm saber percutaneous transluminal angioplasty (pta) balloon catheter.An unknown device was used as a replacement.There were no reported injuries to the patient or signs of infectious disease.This was during a balloon dilatation of the left superficial femoral artery (sfa).Additional information was requested but was not provided.The device will be returned for evaluation.
 
Event or Problem Description
As reported, leakage was detected when inflating the balloon of a 5mm x 20cm saber percutaneous transluminal angioplasty (pta) balloon catheter.An unknown device was used as a replacement.There were no reported injuries to the patient or signs of infectious disease.This was during a balloon dilatation of the left superficial femoral artery (sfa).Additional information was requested but was not provided.The device will be returned for evaluation.Addendum: product evaluation revealed a leakage on the body/shaft of the saber pta balloon catheter.
 
Additional Manufacturer Narrative
Complaint conclusion: as reported, leakage was detected when inflating the balloon of a 5mm x 20cm saber percutaneous transluminal angioplasty (pta) balloon catheter.An unknown device was used as a replacement.There were no reported injuries to the patient or signs of infectious disease.This was during a balloon dilatation of the left superficial femoral artery (sfa).Additional information was requested but was not provided.The device was returned for analysis.A non-sterile ¿saber 5mm20cm 150¿ was received coiled inside of a clear plastic bag.The device was unpacked for product evaluation.A thorough inspection revealed no damages or anomalies during the unaided eye visual inspection.The balloon was received deflated.A functional test was performed using an inflator/deflator device attached to the inflation port.Positive pressure was applied to reach the rated burst pressure, a leak was observed in the shaft of the unit.A high magnification analysis was conducted to evaluate the surface of the balloon.During this analysis, a puncture was located at the site of the leakage.Additionally, scratch marks were observed near the puncture.These scratch marks could be related to the exposure of the balloon surface to sharp edges or mechanical damage which caused the identified leakage.The reported ¿balloon leakage during positive pressure¿ was not confirmed during analysis of the returned device.There were no anomalies noted to the balloon material itself.Subsequent findings of a ¿body/shaft leakage¿ was discovered during functional testing.When the balloon was pressurized with water, a leakage was noted coming from a punctured area on the shaft with scratch marks adjacent to the puncture.This indicates the shaft likely encountered a sharp object from the outside, either during advancement through the vasculature or during attempted inflation at the lesion.Based on the information available for review, vessel characteristics and procedural factors likely contributed to the reported event as evidenced by the analysis of the returned device.According to the instructions for use, which are not intended to mitigate risk, ¿prior to angioplasty, the catheter should be examined to verify functionality and integrity and ensure that its size and shape are suitable for the specific procedure for which it is to be used.Do not use if product damage is suspected or evident.To reduce the potential for vessel damage or the risk of dislodgement of particles it is very important that the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the lesion.Proper functioning of the catheter depends on its integrity.Care should be used when handling the catheter.Damage may result from kinking, stretching, or forceful wiping of the catheter.Forceful handling can result in catheter separation and the subsequent need to use a snare or other medical interventional techniques to retrieve the pieces.¿ the information available, nor the product analysis suggest a design or manufacturing related cause for the reported event.Therefore, no corrective or preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SABER
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
CORDIS US. CORP
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
coyol free zone, building b25, ,  , costa rica
el coyol alajuela bld 25 
7863138372
MDR Report Key20884825
Report Number3007635982-2024-00289
Device Sequence Number7902375
Product Code LIT
UDI-Device Identifier20705032069554
UDI-Public(01)20705032069554(17)251130(10)82270294
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K971010
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date11/30/2025
Device Catalogue Number48005020X
Device Lot Number82270294
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/19/2024
Supplement Date Received by Manufacturer12/13/2024
01/21/2025
Initial Report FDA Received Date12/09/2024
Supplement Report FDA Received Date01/07/2025
02/05/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/19/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AVANTI VASCULAR SHEATH.; TERUMO LOACH GUIDEWIRE.
Patient SexUnknown
-
-